Pharmerica (PMC) Tops Q2 EPS by 4c

Pharmerica (NYSE: PMC) reported Q2 EPS of $0.37, $0.04 better than the analyst estimate of $0.33. Revenue for the quarter came in at $497 million versus the consensus estimate of $491.66 million.

Pharmerica sees FY2015 EPS of $1.55-$1.65, versus the consensus of $1.63. Pharmerica sees FY2015 revenue of $1.95-2.05 billion, versus the consensus of $2.03 billion.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Tilly's, Inc. (TLYS) Tops Q1 EPS by 44c ; offer guidance
• Ulta Beauty (ULTA) Tops Q1 EPS by 87c, Beats on Revenue; Offers FY27 EPS guidance